Migraines are chronic problems for millions of people around the world. To better understand migraine prevalence, let’s consider the following statistics from The Migraine Trust:

  • Migraines are the third most-common disease in the world behind dental caries and tension-type headaches.
  • Globally, migraine prevalence is 14.7%; this means roughly one out of every seven people suffers from migraines.
  • Migraines are more prevalent than asthma, diabetes and epilepsy combined.

Additionally, migraines sometimes go undiagnosed and untreated. In a recent survey of 3,900 individuals conducted by the National Migraine Foundation (NMF), 61% of respondents said they began experiencing migraine symptoms before the age of 19. However, only 26% received a formal migraine diagnosis before adulthood.

The NMF survey also highlighted the struggles of migraine patients to address migraine pain. Most survey respondents said they tried over-the-counter (OTC), abortive, preventive and rescue medications and alternative or complementary therapies to alleviate migraine pain. Yet only 40% were satisfied with their migraine treatment plan.

Dr. Jonathan Cabin of The Migraine Institute helps patients who have received a chronic migraine diagnosis from a neurologist and find their current medications cause intolerable side effects or fail to provide consistent migraine pain relief. He understands there is no one-size-fits-all migraine treatment and allocates time and resources to perform an in-depth patient evaluation. That way, Dr. Cabin can identify a patient’s anatomical migraine triggers and treat these trigger points to relieve migraine pain.

Migraines often start in the forehead, temples, nose or back of the neck, and they may develop due to ongoing irritation of sensory nerves around the face and neck. By targeting anatomical migraine trigger areas, Dr. Cabin reduces or eliminates external triggers that cause migraine pain.

Dr. Cabin offers two migraine treatment options: Botox and minimally invasive surgery. All of the anatomical migraine trigger points except the nose respond to Botox. Meanwhile, trigger point surgery depends on the location of a patient’s migraine pain.

During a Botox treatment, Dr. Cabin injects a small amount of a neurotoxin derived from Clostridium botulinum bacteria into a patient’s skin. The injection temporarily prevents nerve cell signals from reaching the muscles. As a result, a Botox injection paralyzes the muscles and reduces abnormal muscle contraction that otherwise contributes to a patient’s migraine symptoms.

Migraine surgery helps patients permanently eliminate nerve irritants. Dr. Cabin tailors each migraine surgery to a patient’s specific migraine triggers. By doing so, Dr. Cabin often helps patients reduce the duration, intensity and frequency of their migraine symptoms. In fact, approximately 50% of migraine patients report no migraines after migraine surgery.

Before Dr. Cabin administers Botox or migraine surgery treatments, he requests a patient consultation. At this time, Dr. Cabin reviews a patient’s medical history, including a migraine log. Dr. Cabin also conducts a physical exam. He may request a Doppler ultrasound, computed tomography (CT) scan or other specialized patient testing, too.

Once Dr. Cabin conducts a full patient evaluation, he provides a migraine treatment recommendation. If Dr. Cabin determines surgery is the best option to treat migraine pain, he will customize the procedure to address a patient’s specific migraine triggers.

Dr. Cabin strives to help chronic migraine sufferers address their symptoms and achieve long-lasting pain relief. To find out more, please contact us today at 310.461.0303 to schedule a consultation with Dr. Cabin.

Please follow and like us:
0